Excessive daytime somnolence
Information
- Disease name
- Excessive daytime somnolence
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00459420 | Completed | Phase 2/Phase 3 | Caffeine for Excessive Daytime Somnolence in Parkinson's Disease | April 2007 | July 2011 |
| NCT04451668 | Completed | Phase 3 | An Open Label Study of FT218 in Subjects With Narcolepsy | June 12, 2020 | December 22, 2023 |
| NCT05008341 | Completed | Phase 1 | Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration | August 27, 2021 | April 15, 2022 |
| NCT05056194 | Unknown status | Phase 2 | Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study | November 1, 2021 | November 1, 2022 |
| NCT04049682 | Withdrawn | Start Times and Restful Sleep | September 2019 | December 2021 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001262